Go long in Sun Pharmaceutical Industries: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Sun Pharmaceutical Industries had a big decline. After this big decline, it has had a small stable trading range. Very small, but it is now beginning an upmove. Now, it could, we are assuming that the downside correction is over. There is never a guarantee.""For bluechips, a big decline is a correction and that correction for Sun Pharmaceutical is over. So, if it is over, yesterday was a good day, we should assume this momentum will continue. We go long in the stock," he said.